Prof. BAUTISTA José

Prof. BAUTISTA José

Professor of Biochemistry and Molecular Biology

University Complutense of Madrid
Ciudad Universitaria, Madrid, Spain, E-28040

plus Speciality

HAEMATOLOGY

Biography:

Dr. José Manuel Bautista is Professor and Director of the Department of Biochemistry and Molecular Biology IV at the Universidad Complutense de Madrid. He is also coordinator of the research group “Translational Haematology II” at the Research Institute Hospital 12 de Octubre in the University Hospital 12 de Octubre in Madrid. After receiving his Ph.D. in Biochemistry in 1987, he was a Postdoctoral Fellow at the Royal Postgraduate Medical School in London (1988-1991) where specialized in haematology of the red cell, and joined the Faculty at UCM in 1991. He has worked in human G6PD deficiency and in malaria, including research sites in Ghana. In addition to teaching at UCM, he has been visiting scientist at Imperial College of Medicine in London (1995-96: 1 year), CNR-Naples (2000: 3 months), University of Developmental Studies-Ghana (2005: 1 month) and Université Cheikh Anta Diop in Senegal (2012-1 month).

Academic positions:

- Lecturer in Biochemistry - University of Extremadura - (Spain) 1984-1988

- Postdoctoral Research Fellow (Haematology) - Royal Postgraduate Medical School (London, UK) 1988-1990

- Senior Lecturer of Biochemistry and Molecular Biology - University Complutense of Madrid (Spain) 1990-2007

- Visiting Scientist - Imperial College (London, UK) -1995-96

-Professor of Biochemistry and Molecular Biology - University Complutense of Madrid (Spain) 2007-present

- Coordinator of Translational Haematology II at Research Institute Hospital 12 de Octubre in the University Hospital 12 de Octubre (Madrid- Spain) 2009-present

- Director Department of Biochemistry and Molecular Biology IV - University Complutense of Madrid (Spain) 2009 - present.

Research interests:

The main research interests of the Prof. Bautista’s group are in the area of oxidative stress effectors to responses to malaria disease, particularly to responses leading to protection of the host, like G6PD deficiency.  In addition, the group is interested in the field of drug discovery and therapeutics in relation to immune modulation in malaria infection. For these main research activities the group focus on several animal model of the disease, proteomics (redox-proteomics and immunoproteomics), factors that influence pathogenicity of malaria, and the evaluation of immune-efficacy of antimalarial drugs.

What I think of the idea behind WebmedCentral and WebmedCentral plus:

I believe that open publications on internet are fundamental for both, universal access to scientific knowledge and fast scientific discovery. In addition, this would eventually lead to an improved translation of science to society. In this context WebMed Central is a significant step forward to provide the most recent scientific results in a transparent, creative and constructive way of evaluating them. Post-publication review guarantees innovation in science and avoid biased criticism by the mainstream beliefs that deter and delay public access to new information. This model of scientific publishing allows the readers, not the editors, to have their own view on the quality and outreach of the work done by others and consequently take it or not into account.